RESEARCH INVOLVING… |
IRB |
Chemotherapeutic drugs to treat malignant tumors OR the following nonmalignant tumors:
- Meningiomas
- Schwannomas
- Neurofibromas
- Pancreatic cysts
- Neuroendocrine pancreatic tumors
|
DFCI |
Radiological diagnostic techniques directed at patients with cancer or follow-up of cancer therapy |
DFCI |
Cryotherapy or radioablation of malignant tumors |
DFCI |
Novel surgical approaches to cancer therapy |
DFCI |
Pain management/alternative medicine approaches to cancer therapy |
DFCI |
Cancer prevention in populations at high risk of cancer (e.g., pre-cancerous lesions) |
DFCI |
Treatment of the following nonmalignant tumors, with the exception of treatment involving chemotherapeutic drugs:
- Meningiomas
- Schwannomas
- Neurofibromas
- Pancreatic cysts
- Neuroendocrine pancreatic tumors
|
PHS |
Treatment of osteomas or pituitary adenomas |
PHS |
Treatment of warts/localized papillomas |
PHS |
Treatment of nonmalignant hematology |
PHS |
Populations with and without cancer (mixed populations); for example, studies of pain, infectious diseases, radiology/imaging, surgery, diagnosis |
PHS |
Nursing practice directed at patients with cancer |
PHS |
Collection of blood/tissue for genetic testing directed at cancer patients |
PHS* |
Health/medical records of cancer patients |
PHS |
Tissue samples derived from cancer patients |
PHS* |
Questionnaires/surveys directed at patients with cancer |
PHS* |
Tissue banks/repositories |
TBD |
Cancer prevention in the general population |
PHS |
*PHS IRB will report protocols falling within this category that it reviews to the DFCI IRB for purposes of reporting to NCI. |
